controversy debate 1: is it justified to move from adjuvant to neo-adjuvant treatment? - no
Published 8 years ago • 210 plays • Length 11:12Download video MP4
Download video MP3
Similar videos
-
16:17
controversy debate 1: is it justified to move from adjuvant to neo-adjuvant treatment? - yes
-
24:43
is adjuvant or neo-adjuvant treatment for pancreatic cancer the way to go?
-
10:49
controversy debate 3: neo-adjuvant/adjuvant treatment in gastric cancer - the eu view
-
5:54
adjuvant and neoadjuvant therapy side effects-dr. david margileth
-
13:00
controversy debate 3: neo-adjuvant/adjuvant treatment in gastric cancer - the surgical point of view
-
10:22
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - total neoadjuvant
-
12:43
debate: treatment for resectable pancreatic cancer? - neo-adjuvant chemotherapy
-
1:03:39
deep insight into immuno-oncology: immunotherapy pathways, targets, and biomarkers
-
3:06
what is adjuvant or neoadjuvant treatment? [part 2 - video 7]
-
1:35
what is neoadjuvant therapy?
-
4:03
what are the advantages and disadvantages of neoadjuvant and adjuvant therapies? (douglas evans, md)
-
10:48
debate: adjuvant treatment of pancreatic cancer - monotherapy
-
13:42
debate: optimal neoadjuvant strategy in pancreatic cancer - chemotherapy alone
-
10:50
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - adjuvant therapy
-
10:28
debate: treatment for resectable pancreatic cancer? - surgery adjuvant chemotherapy
-
13:07
adjuvant and neoadjuvant therapy in melanoma
-
14:39
debate: adjuvant therapy for resected node negative stage i nsclc? - sometimes
-
27:18
adjuvant and neoadjuvant dilemmas
-
18:26
when to choose for neo-adjuvant instead of adjuvant treatment in pancreatic cancer?
-
13:56
adjuvant therapy - chemotherapy issues
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
11:56
debate: adjuvant therapy for resected node negative stage i nsclc? - never